Isis Pharmaceuticals 2Q Earnings Down on Rising Costs
August 09, 2010 at 10:52 AM EDT
Shares of Isis Pharmaceuticals Inc. were trading in the red Monday after the drug maker reported worse-than-expected second-quarter earnings, due primarily to rising costs that could not be fully offset by partnership-related revenues.
